Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Feb;142(2):219–229.

Pathogenesis of Impaired Glucose Tolerance and Type II Diabetes Mellitus—Current Status

Mayer B Davidson 1
PMCID: PMC1305982  PMID: 3892914

Abstract

The insulin response to glucose taken orally is increased in patients with impaired glucose tolerance (IGT) but decreased in those with type II diabetes mellitus. The insulin response to meals, however, is normal in patients with type II diabetes, although the glucose concentrations are obviously elevated. The acute insulin response to intravenously administered glucose is absent in cases of both IGT and type II diabetes when the fasting plasma glucose level exceeds 115 mg per dl. On the other hand, the response to other intravenously given secretagogues is either normal or nearly so. The absent acute insulin response to intravenously administered glucose can be restored by α-adrenergic blockade, prostaglandin synthesis inhibition, dopaminergic blockade and euglycemia.

Insulin antagonism characterizes patients with both IGT and type II diabetes. Those with IGT and mild diabetes mellitus (untreated fasting plasma glucose concentrations < 180 mg per dI) have a receptor defect probably due to down regulation. Diabetic patients with more severe type II diabetes show a postreceptor defect. The relation (if any) between receptor and postreceptor defects is unclear.

Full text

PDF
226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagdade J. D., Bierman E. L., Porte D., Jr Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects. Metabolism. 1971 Nov;20(11):1000–1007. doi: 10.1016/0026-0495(71)90022-9. [DOI] [PubMed] [Google Scholar]
  2. Bagdade J. D., Bierman E. L., Porte D., Jr The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest. 1967 Oct;46(10):1549–1557. doi: 10.1172/JCI105646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beck-Nielsen H. The pathogenic role of an insulin-receptor defect in diabetes mellitus of the obese. Diabetes. 1978 Dec;27(12):1175–1181. doi: 10.2337/diab.27.12.1175. [DOI] [PubMed] [Google Scholar]
  4. Bolinder J., Ostman J., Arner P. Postreceptor defects causing insulin resistance in normoinsulinemic non-insulin-dependent diabetes mellitus. Diabetes. 1982 Oct;31(10):911–916. doi: 10.2337/diab.31.10.911. [DOI] [PubMed] [Google Scholar]
  5. Brunzell J. D., Robertson R. P., Lerner R. L., Hazzard W. R., Ensinck J. W., Bierman E. L., Porte D., Jr Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976 Feb;42(2):222–229. doi: 10.1210/jcem-42-2-222. [DOI] [PubMed] [Google Scholar]
  6. Caro J. F., Amatruda J. M. Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes. J Clin Invest. 1982 Apr;69(4):866–875. doi: 10.1172/JCI110526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chevaux F., Curchod B., Felber J. P., Jéquier E. Insulin resistance and carbohydrate oxidation in patients with chemical diabetes. Diabete Metab. 1982 Jun;8(2):105–108. [PubMed] [Google Scholar]
  8. Ciaraldi T. P., Kolterman O. G., Scarlett J. A., Kao M., Olefsky J. M. Role of glucose transport in the postreceptor defect of non-insulin-dependent diabetes mellitus. Diabetes. 1982 Nov;31(11):1016–1022. doi: 10.2337/diacare.31.11.1016. [DOI] [PubMed] [Google Scholar]
  9. Crockford P. M., Hazzard W. R., Williams R. H. Insulin response to glucagon. The opposing effects of diabetes and obesity. Diabetes. 1969 Apr;18(4):216–224. doi: 10.2337/diab.18.4.216. [DOI] [PubMed] [Google Scholar]
  10. Davidson M. B., Kaplan S. A. Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy. J Clin Invest. 1977 Jan;59(1):22–30. doi: 10.1172/JCI108618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Davis B. M., Bernstein R., Kolterman O., Olefsky J. M., Reaven G. M. Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes. 1979 Jan;28(1):32–34. doi: 10.2337/diab.28.1.32. [DOI] [PubMed] [Google Scholar]
  12. DeFronzo R. A., Simonson D., Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982 Oct;23(4):313–319. doi: 10.1007/BF00253736. [DOI] [PubMed] [Google Scholar]
  13. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  14. DeFronzo R., Deibert D., Hendler R., Felig P., Soman V. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. J Clin Invest. 1979 May;63(5):939–946. doi: 10.1172/JCI109394. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  15. DePirro R., Fusco A., Lauro R., Testa I., Ferreti F., DeMartinis C. Erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus. Diabetes. 1980 Feb;29(2):96–99. doi: 10.2337/diab.29.2.96. [DOI] [PubMed] [Google Scholar]
  16. Fink R. I., Kolterman O. G., Griffin J., Olefsky J. M. Mechanisms of insulin resistance in aging. J Clin Invest. 1983 Jun;71(6):1523–1535. doi: 10.1172/JCI110908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Foley J. E., Kashiwagi A., Verso M. A., Reaven G., Andrews J. Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes. J Clin Invest. 1983 Dec;72(6):1901–1909. doi: 10.1172/JCI111153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Frank H. J., Davidson M. B. Insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting. Am J Physiol. 1982 Sep;243(3):E240–E245. doi: 10.1152/ajpendo.1982.243.3.E240. [DOI] [PubMed] [Google Scholar]
  19. Frank H. J., Davidson M. B., Serbin P. A. Insulin binding and action in isolated rat hepatocytes: evidence for spare receptors. Metabolism. 1981 Dec;30(12):1159–1164. doi: 10.1016/0026-0495(81)90035-4. [DOI] [PubMed] [Google Scholar]
  20. Gavin J. R., 3rd, Roth J., Neville D. M., Jr, de Meyts P., Buell D. N. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A. 1974 Jan;71(1):84–88. doi: 10.1073/pnas.71.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gelehrter T., Dilworth V., Valka B., McDonald R., Schorry E. Insulin binding and insulin action in fibroblasts from patients with maturity-onset diabetes of the young. Diabetes. 1981 Nov;30(11):940–946. doi: 10.2337/diab.30.11.940. [DOI] [PubMed] [Google Scholar]
  22. Ginsberg H., Kimmerling G., Olefsky J. M., Reaven G. M. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest. 1975 Mar;55(3):454–461. doi: 10.1172/JCI107951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ginsberg H., Olefsky J. M., Reaven G. M. Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes. 1974 Aug;23(8):674–678. doi: 10.2337/diab.23.8.674. [DOI] [PubMed] [Google Scholar]
  24. Ginsberg H., Rayfield E. J. Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity. Diabetes. 1981 Sep;30(9):739–745. doi: 10.2337/diab.30.9.739. [DOI] [PubMed] [Google Scholar]
  25. Giugliano D., Cerciello T., Giannetti G., Ceriello A., Giunta R., Frascolla N. Impaired insulin secretion in human diabetes mellitus. I. The effect of alpha-adrenergic inhibition. Pharmacol Res Commun. 1982 Mar;14(3):217–225. doi: 10.1016/s0031-6989(82)80031-3. [DOI] [PubMed] [Google Scholar]
  26. Giugliano D., Ceriello A., di Pinto P., Saccomanno F., Gentile S., Cappiapuoti F. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes. 1982 Apr;31(4 Pt 1):367–370. doi: 10.2337/diab.31.4.367. [DOI] [PubMed] [Google Scholar]
  27. Goldstein S., Blecher M., Binder R., Perrino P. V., Recant L. Hormone receptors, 5. Binding of glucagon and insulin to human circulating mononuclear cells in diabetes mellitus. Endocr Res Commun. 1975;2(4-5):367–376. doi: 10.1080/07435807509089009. [DOI] [PubMed] [Google Scholar]
  28. Greenfield M. S., Doberne L., Kraemer F., Tobey T., Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes. 1981 May;30(5):387–392. doi: 10.2337/diab.30.5.387. [DOI] [PubMed] [Google Scholar]
  29. Grunfeld C., Baird K., Van Obberghen E., Kahn C. R. Glucocorticoid-induced insulin resistance in vitro: evidence for both receptor and postreceptor defects. Endocrinology. 1981 Nov;109(5):1723–1730. doi: 10.1210/endo-109-5-1723. [DOI] [PubMed] [Google Scholar]
  30. Harano Y., Hidaka H., Takatsuki K., Ohgaku S., Haneda M., Motoi S., Kawagoe K., Shigeta Y., Abe H. Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism. 1978 Sep;27(9 Suppl 1):1449–1452. doi: 10.1016/0026-0495(78)90091-4. [DOI] [PubMed] [Google Scholar]
  31. Harano Y., Ohgaku S., Kosugi K., Yasuda H., Nakano T., Kobayashi M., Hidaka H., Izumi K., Kashiwagi A., Shigeta Y. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion. J Clin Endocrinol Metab. 1981 May;52(5):982–987. doi: 10.1210/jcem-52-5-982. [DOI] [PubMed] [Google Scholar]
  32. Harewood M. S., Proietto J., Dudley F., Alford F. P. Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytes. Metabolism. 1982 Dec;31(12):1241–1246. doi: 10.1016/0026-0495(82)90011-7. [DOI] [PubMed] [Google Scholar]
  33. Helderman J. H., Raskin P. The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defect. Diabetes. 1980 Jul;29(7):551–557. doi: 10.2337/diab.29.7.551. [DOI] [PubMed] [Google Scholar]
  34. Hidaka H., Nagulesparan M., Klimes I., Clark R., Sasaki H., Aronoff S. L., Vasquez B., Rubenstein A. H., Unger R. H. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. J Clin Endocrinol Metab. 1982 Feb;54(2):217–222. doi: 10.1210/jcem-54-2-217. [DOI] [PubMed] [Google Scholar]
  35. Häring H. U., Rinninger F., Kemmler W. Decreased insulin sensitivity due to a postreceptor defect as a consequence of ATP-deficiency in fat cells. FEBS Lett. 1981 Sep 28;132(2):235–238. doi: 10.1016/0014-5793(81)81168-4. [DOI] [PubMed] [Google Scholar]
  36. Kahn C. R., Freychet P., Roth J., Neville D. M., Jr Quantitative aspects of the insulin-receptor interaction in liver plasma membranes. J Biol Chem. 1974 Apr 10;249(7):2249–2257. [PubMed] [Google Scholar]
  37. Kahn C. R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978 Dec;27(12 Suppl 2):1893–1902. doi: 10.1016/s0026-0495(78)80007-9. [DOI] [PubMed] [Google Scholar]
  38. Kashiwagi A., Verso M. A., Andrews J., Vasquez B., Reaven G., Foley J. E. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J Clin Invest. 1983 Oct;72(4):1246–1254. doi: 10.1172/JCI111080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Kimmerling G., Javorski C., Olefsky J. M., Reaven G. M. Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus. Diabetes. 1976 Aug;25(8):673–678. doi: 10.2337/diab.25.8.673. [DOI] [PubMed] [Google Scholar]
  40. Klotz I. M. Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science. 1982 Sep 24;217(4566):1247–1249. doi: 10.1126/science.6287580. [DOI] [PubMed] [Google Scholar]
  41. Kobayashi M., Ohgaku S., Iwasaki M., Harano Y., Maegawa H., Shigeta Y. Evaluation of the method of insulin binding studies in human erythrocytes. Endocrinol Jpn. 1980 Jun;27(3):337–342. doi: 10.1507/endocrj1954.27.337. [DOI] [PubMed] [Google Scholar]
  42. Kobayashi M., Olefsky J. M., Elders J., Mako M. E., Given B. D., Schedwie H. K., Fiser R. H., Hintz R. L., Horner J. A., Rubenstein A. H. Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3469–3473. doi: 10.1073/pnas.75.7.3469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kolterman O. G., Gray R. S., Griffin J., Burstein P., Insel J., Scarlett J. A., Olefsky J. M. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest. 1981 Oct;68(4):957–969. doi: 10.1172/JCI110350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kolterman O. G., Insel J., Saekow M., Olefsky J. M. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980 Jun;65(6):1272–1284. doi: 10.1172/JCI109790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lampman R. M., Santinga J. T., Bassett D. R., Savage P. J. Cardiac arrhythmias during epinephrine-propranolol infusions for measurement of in vivo insulin resistance. Diabetes. 1981 Jul;30(7):618–620. doi: 10.2337/diab.30.7.618. [DOI] [PubMed] [Google Scholar]
  46. Le Marchand-Brustel Y., Jeanrenaud B., Freychet P. Insulin binding and effects in isolated soleus muscle of lean and obese mice. Am J Physiol. 1978 Apr;234(4):E348–E358. doi: 10.1152/ajpendo.1978.234.4.E348. [DOI] [PubMed] [Google Scholar]
  47. Lerner R. L. Augmented insulin responses to glucose after secretin priming in diabetic subjects. J Clin Endocrinol Metab. 1979 Mar;48(3):462–466. doi: 10.1210/jcem-48-3-462. [DOI] [PubMed] [Google Scholar]
  48. Lerner R. L., Porte D., Jr Uniphasic insulin responses to secretin stimulation in man. J Clin Invest. 1970 Dec;49(12):2276–2280. doi: 10.1172/JCI106447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Liu G., Coulston A., Chen Y. D., Reaven G. M. Does day-long absolute hypoinsulinemia characterize the patient with non-insulin-dependent diabetes mellitus? Metabolism. 1983 Aug;32(8):754–756. doi: 10.1016/0026-0495(83)90104-x. [DOI] [PubMed] [Google Scholar]
  50. Luft R., Wajngot A., Efendić S. On the pathogenesis of maturity-onset diabetes. Diabetes Care. 1981 Jan-Feb;4(1):58–63. doi: 10.2337/diacare.4.1.58. [DOI] [PubMed] [Google Scholar]
  51. Lönnroth P., Digirolamo M., Krotkiewski M., Smith U. Insulin binding and responsiveness in fat cells from patients with reduced glucose tolerance and type II diabetes. Diabetes. 1983 Aug;32(8):748–754. doi: 10.2337/diab.32.8.748. [DOI] [PubMed] [Google Scholar]
  52. Nagulesparan M., Savage P. J., Mott D. M., Johnson G. C., Unger R. H., Bennett P. H. Increased insulin resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained by obesity. J Clin Endocrinol Metab. 1980 Oct;51(4):739–743. doi: 10.1210/jcem-51-4-739. [DOI] [PubMed] [Google Scholar]
  53. Nankervis A., Proietto J., Aitken P., Harewood M., Alford F. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes. Diabetologia. 1982 Oct;23(4):320–325. doi: 10.1007/BF00253737. [DOI] [PubMed] [Google Scholar]
  54. Oka Y., Ezaki O., Akanuma Y., Kosaka K. Insulin binding of erythrocytes in hypoinsulinemic diabetics and its relationship to metabolic states. Endocrinol Jpn. 1981 Oct;28(5):615–622. doi: 10.1507/endocrj1954.28.615. [DOI] [PubMed] [Google Scholar]
  55. Okamoto M., Kuzuya H., Seino Y., Ikeda M., Imura H. Insulin binding to erythrocytes in diabetic patients. Endocrinol Jpn. 1981 Apr;28(2):169–173. doi: 10.1507/endocrj1954.28.169. [DOI] [PubMed] [Google Scholar]
  56. Olefsky J. M. Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest. 1975 Dec;56(6):1499–1508. doi: 10.1172/JCI108231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Olefsky J. M. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes. 1981 Feb;30(2):148–162. doi: 10.2337/diab.30.2.148. [DOI] [PubMed] [Google Scholar]
  58. Olefsky J. M., Marshall S., Berhanu P., Saekow M., Heidenreich K., Green A. Internalization and intracellular processing of insulin and insulin receptors in adipocytes. Metabolism. 1982 Jul;31(7):670–690. doi: 10.1016/0026-0495(82)90197-4. [DOI] [PubMed] [Google Scholar]
  59. Olefsky J. M., Reaven G. M. Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest. 1974 Dec;54(6):1323–1328. doi: 10.1172/JCI107878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Olefsky J. M., Reaven G. M. Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes. 1977 Jul;26(7):680–688. doi: 10.2337/diab.26.7.680. [DOI] [PubMed] [Google Scholar]
  61. Olefsky J. M., Reaven G. M. Insulin binding to monocytes and total mononuclear leukocytes from normal and diabetic patients. J Clin Endocrinol Metab. 1976 Jul;43(1):226–231. doi: 10.1210/jcem-43-1-226. [DOI] [PubMed] [Google Scholar]
  62. Olefsky J. M., Sperling M. A., Reaven G. M. Does glucagon play a role in the insulin resistance of patients with adult non-ketotic diabetes? Diabetologia. 1977 Aug;13(4):327–330. doi: 10.1007/BF01223274. [DOI] [PubMed] [Google Scholar]
  63. Olefsky J. M. The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest. 1976 Apr;57(4):842–851. doi: 10.1172/JCI108360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Pagano G., Cassader M., Lenti G. Insulin receptors in adipocytes of non-diabetic and diabetic subjects. Preliminary report. Acta Diabetol Lat. 1977 May-Aug;14(3-4):164–169. doi: 10.1007/BF02581404. [DOI] [PubMed] [Google Scholar]
  65. Palmer J. P., Benson J. W., Walter R. M., Ensinck J. W. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. J Clin Invest. 1976 Sep;58(3):565–570. doi: 10.1172/JCI108502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Pfeifer M. A., Halter J. B., Porte D., Jr Insulin secretion in diabetes mellitus. Am J Med. 1981 Mar;70(3):579–588. doi: 10.1016/0002-9343(81)90579-9. [DOI] [PubMed] [Google Scholar]
  67. Prince M. J., Tsai P., Olefsky J. M. Insulin binding, internalization, and insulin receptor regulation in fibroblasts from type II, non-insulin-dependent diabetic subjects. Diabetes. 1981 Jul;30(7):596–600. doi: 10.2337/diab.30.7.596. [DOI] [PubMed] [Google Scholar]
  68. Ratzmann K. P., Besch W., Witt S., Schulz B. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance. Diabetologia. 1981 Sep;21(3):192–197. doi: 10.1007/BF00252653. [DOI] [PubMed] [Google Scholar]
  69. Reaven G. M., Bernstein R., Davis B., Olefsky J. M. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med. 1976 Jan;60(1):80–88. doi: 10.1016/0002-9343(76)90536-2. [DOI] [PubMed] [Google Scholar]
  70. Reaven G. M., Doberne L., Greenfield M. S. Comparison of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with non-insulin-dependent diabetes mellitus. Diabetes. 1982 May;31(5 Pt 1):382–384. doi: 10.2337/diab.31.5.382. [DOI] [PubMed] [Google Scholar]
  71. Reaven G. M., Olefsky J. M. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia. 1977 May;13(3):201–206. doi: 10.1007/BF01219700. [DOI] [PubMed] [Google Scholar]
  72. Rizza R. A., Mandarino L. J., Gerich J. E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab. 1982 Jan;54(1):131–138. doi: 10.1210/jcem-54-1-131. [DOI] [PubMed] [Google Scholar]
  73. Rizza R. A., Mandarino L. J., Gerich J. E. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes. 1982 Aug;31(8 Pt 1):663–669. doi: 10.2337/diab.31.8.663. [DOI] [PubMed] [Google Scholar]
  74. Rizza R. A., Mandarino L. J., Gerich J. E. Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes. 1981 Dec;30(12):990–995. doi: 10.2337/diab.30.12.990. [DOI] [PubMed] [Google Scholar]
  75. Robertson R. P., Halter J. B., Porte D., Jr A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest. 1976 Mar;57(3):791–795. doi: 10.1172/JCI108338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Robertson R. P., Porte D., Jr The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest. 1973 Apr;52(4):870–876. doi: 10.1172/JCI107251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Robinson T. J., Archer J. A., Gambhir K. K., Hollis V. W., Jr, Carter L., Bradley C. Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans. Science. 1979 Jul 13;205(4402):200–202. doi: 10.1126/science.451590. [DOI] [PubMed] [Google Scholar]
  78. Rowe J. W., Minaker K. L., Pallotta J. A., Flier J. S. Characterization of the insulin resistance of aging. J Clin Invest. 1983 Jun;71(6):1581–1587. doi: 10.1172/JCI110914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Savage P. J., Bennion L. J., Flock E. V., Nagulesparan M., Mott D., Roth J., Unger R. H., Bennett P. H. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J Clin Endocrinol Metab. 1979 Jun;48(6):999–1007. doi: 10.1210/jcem-48-6-999. [DOI] [PubMed] [Google Scholar]
  80. Savage P. J., Dippe S. E., Bennett P. H., Gorden P., Roth J., Rushforth N. B., Miller M. Hyperinsulinemia and hypoinsulinemai. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance. Diabetes. 1975 Apr;24(4):362–368. doi: 10.2337/diab.24.4.362. [DOI] [PubMed] [Google Scholar]
  81. Scarlett J. A., Gray R. S., Griffin J., Olefsky J. M., Kolterman O. G. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care. 1982 Jul-Aug;5(4):353–363. doi: 10.2337/diacare.5.4.353. [DOI] [PubMed] [Google Scholar]
  82. Scarlett J. A., Kolterman O. G., Ciaraldi T. P., Kao M., Olefsky J. M. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab. 1983 Jun;56(6):1195–1201. doi: 10.1210/jcem-56-6-1195. [DOI] [PubMed] [Google Scholar]
  83. Scarlett J. A., Kolterman O. G., Moore P., Saekow M., Insel J., Griffin J., Mako M., Rubenstein A. H., Olefsky J. M. Insulin resistance and diabetes due to a genetic defect in insulin receptors. J Clin Endocrinol Metab. 1982 Jul;55(1):123–131. doi: 10.1210/jcem-55-1-123. [DOI] [PubMed] [Google Scholar]
  84. Schulz B., Doberne L., Greenfield M., Reaven G. M. Insulin receptor binding and insulin-mediated glucose uptake in type-II-diabetics. Exp Clin Endocrinol. 1983 Jan;81(1):49–58. doi: 10.1055/s-0029-1210206. [DOI] [PubMed] [Google Scholar]
  85. Shen S. W., Reaven G. M., Farquhar J. W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest. 1970 Dec;49(12):2151–2160. doi: 10.1172/JCI106433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Soli A. H., Kahn C. R., Neville D. M., Jr, Roth J. Insulin receptor deficiency in genetic and acquired obesity. J Clin Invest. 1975 Oct;56(4):769–780. doi: 10.1172/JCI108155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Taylon A., Blackard W. G. Role of insulin receptors in obesity-related diabetes. Horm Metab Res. 1982 Dec;14(12):623–626. doi: 10.1055/s-2007-1019102. [DOI] [PubMed] [Google Scholar]
  88. Vague P., Moulin J. P. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Metabolism. 1982 Feb;31(2):139–142. doi: 10.1016/0026-0495(82)90125-1. [DOI] [PubMed] [Google Scholar]
  89. Ward W. K., Halter J. B., Best J. D., Beard J. C., Porte D., Jr Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man. Diabetes. 1983 Oct;32(10):943–947. doi: 10.2337/diab.32.10.943. [DOI] [PubMed] [Google Scholar]
  90. YALOW R. S., BERSON S. A. Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic. Diabetes. 1960 Jul-Aug;9:254–260. doi: 10.2337/diab.9.4.254. [DOI] [PubMed] [Google Scholar]
  91. de Meyts P., Roth J., Neville D. M., Jr, Gavin J. R., 3rd, Lesniak M. A. Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun. 1973 Nov 1;55(1):154–161. doi: 10.1016/s0006-291x(73)80072-5. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES